Company Filing History:
Years Active: 2009-2010
Title: The Innovations of Christopher M. Jackson
Introduction
Christopher M. Jackson is an accomplished inventor based in Gahanna, Ohio. He has made significant contributions to the field of medical science, particularly in the development of potassium channel inhibitors. With a total of two patents to his name, Jackson's work focuses on providing effective treatments for cardiac arrhythmia.
Latest Patents
Jackson's latest patents revolve around Kv1.5 potassium channel inhibitors. The present invention relates to 1-N-amino-2-imidazolidinones and derivatives thereof, which are effective as Kv1.5 potassium channel inhibitors. These compounds provide atrial-selective antiarrhythmic agents. Furthermore, the invention includes compositions comprising these Kv1.5 potassium channel inhibitors and methods for treating cardiac arrhythmia.
Career Highlights
Christopher M. Jackson is currently associated with Wyeth, a prominent company in the pharmaceutical industry. His work at Wyeth has allowed him to focus on innovative solutions for heart-related conditions, contributing to advancements in medical treatments.
Collaborations
Some of Jackson's notable coworkers include John M. Janusz and Stephen Joseph Hodson. Their collaboration has likely fostered an environment of innovation and creativity in their respective projects.
Conclusion
Christopher M. Jackson's contributions to the field of medical science through his patents on Kv1.5 potassium channel inhibitors highlight his dedication to improving cardiac health. His work continues to pave the way for advancements in antiarrhythmic treatments.